Chinese OEM has begun manufacturing cars with Cipia’s DMS

The israeli Cipia (formerly Eyesight) reported that the first model of a car equipped with the driver monitoring system it has developed will be hitting the roads in China during this month. The company is collaborating with a Chinese automaker, which has chosen to implement Eyesight’s solution in one of its new models, whose production began last month. Eyesight hopes that the initial adoption will lead to the implementation of the system in other models from the same manufacturer.

Cipia’s Driver Sense DMS utilizes AI and computer vision to monitor the driver for signs of distraction and drowsiness behind the wheel to help create a safer driving experience. The company monitors important factors including gaze vector, blink rate, and eye openness to monitor for dangerous situations and also includes the ability to monitor the driver accurately with a facemask present, proper seat belt usage detection as well as cigarette smoking detection.

Earlier this month, Cipia announced that a leading U.S-based automaker has doubled the volume of systems ordered from Cipia to $30 million, intended to be integrated into a new model scheduled to be launched in 2021. So far, Cipia has achieved 10 design wins.

The Chinese car market is the largest and fastest-growing car market in the world, and also the first to bounce back after the severe impact of the COVID-19 crisis on the world car industry. The Chinese market is also considered to be advanced in terms of adopting new technologies and advancing safety regulations. The issue of regulation is of crucial importance for the driver monitoring systems market. Already last year, some provinces in China began requiring the installation of driver monitoring systems in new vehicles. Indeed, according to Research & Markets, in 2019 over 10,000 DMS systems were sold in China, a spike of 174% compared to a year earlier, and in the first quarter of 2020 about 5,000 systems were installed, a rate that reflects an annual growth of more than 300%.